Is differential pricing the way of the future for the drug industry? News item 14 January 2013 Pages: 1 - 1
Lamivudine a winner for preventing vertical transmission of HBV Clinical study 14 January 2013 Pages: 3 - 3
HeartMate II misses the beat for patients waiting for transplant Clinical study 14 January 2013 Pages: 5 - 5
Lipocalin: cost-effective biomarker of AKI after cardiac surgery Clinical study 14 January 2013 Pages: 5 - 5
Sonographic-guided intra-articular injection best for osteoarthritis Clinical study 14 January 2013 Pages: 5 - 5
Herpes zoster vax cost effective in older adults in Belgium? Clinical study 14 January 2013 Pages: 6 - 6
Most cost-effective therapies for urinary incontinence in Sweden . . . Clinical study 14 January 2013 Pages: 7 - 7
Erlotinib, docetaxel better value than pemetrexed for NSCLC Clinical study 14 January 2013 Pages: 8 - 8
Prostate Health Index: a valuable addition to PSA testing? Clinical study 14 January 2013 Pages: 9 - 9
Ruxolitinib has a positive impact on QOL in myelofibrosis patients Clinical study 14 January 2013 Pages: 9 - 9
Pfizer and GSK extend pneumonia vaccine agreements with GAVI News item 14 January 2013 Pages: 10 - 10
Big changes ahead for dyslipidaemia drug market in the USA Media release 14 January 2013 Pages: 11 - 11
One third of MRSA drug market dominated by Teflaro and tedizolid Media release 14 January 2013 Pages: 11 - 11